🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#MAO2025 📢 Découvrez le programme scientifique final du congrès 👩‍⚕️ 👨‍⚕️ Planifiez votre participation par aires thérapeutiques et thématiques d’intérêt Consultez le programme et inscrivez-vous en ligne 👉 mao-monaco.org/2025/?page_id=… #oncologie #oncogériatrie #cancers #congrès

💡 Bridge research & practice at #SIOG2025! ✔️ Share findings that address real-world challenges ✔️ Inspire actionable change in #CancerCare for #OlderAdults ✔️ Collaborate with global experts Submit your abstract before April 29 loom.ly/HnWmDOs #SIOG25 #GeriatricOncology

#MAO2025 🎥Retour en images sur le Monaco Age Oncologie 👩‍⚕️Le Dr Camille Chakiba-Brugère, lauréate du Prix Michel Hery pour le Meilleur Travail Original, nous parle de l’étude PRIORITY #oncologie #oncogeriatrie#Monaco

SIOG is celebrating 25 years of advancing GO! Submit your abstract for #SIOG2025 to: 🔍 Gain visibility & global reach 🎤 Engage with field leaders 🌐 Expand your network 🏆 Be in the running for prestigious awards loom.ly/HpHA3u8 #SIOG25 #GeriOnc

🆕review article in press: Efficacy assessment in phase I clinical trials: endpoints and challenges Mohamed A Gouda, Ignacio Garrido-Laguna, Pablo A. Ballesteros

Arrived in Paris for the SIOG Geriatric Oncology research Masterclass Gustave Roussy Looking forward to working with an amazing group of researchers! #gerionc #globonc

Great talk by Enrique Soto on research in disparities and resource-limited settings to help start SIOG Masterclass #GeriOnc

Feasibility of home step-tracking using wearable devices for older adults undergoing thoracic surgery: A brief report geriatriconcology.net/article/S1879-… William Dale, MD, PhD, FASCO Cancer and Aging Research Group (CARG) #GeriOnc #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #ThoracicSurgery #WearableDevices

The #SIOGMasterclass in Paris is off to a strong start! Next-gen leaders are stepping up in #CancerCare for older adults. Stay tuned! #GeriOnc #SIOG25 #SIOG2025

🎯 Clinical trial projects presented by delegates 💡 Dr Battisti on why older patients need dedicated trials 🌍 Dr Soto on research in resource-limited settings 📊 Dr Jean on massive clinical datasets in #GeriatricOncology 🛠️ Practical workshops

1/ 🛠️ The day opened with strategies for implementing geriatric parameters in clinical trials and the importance of QoL assessments and PROs in improving patient care.

Don't miss it!!

Début de la huitième journée scientifique de Dialog, consacrée aux cancers colorectaux et à l'implication des patients dans la recherche en onco-gériatrie.

🎙️Inspiring talk by Dr Demetris Papamichael during DIALOG Scientific day on the care of older adults with colorectal cancer SoFOG SIOG Young SIOG

🌍 Ready to meet, learn & grow with the global #GeriOnc community? #YSIOG #SIOG25 #OncoGeriatric

New drugs @ASCO2025 Gustave Roussy

It was a pleasure to sit down with Joaquin Mateo from Vall d’Hebron Institute of Oncology (VHIO) & Capu B from Gustave Roussy for ecancer to discuss emerging #Phase1 therapies such as #ADCs and T-cell engagers 🔗 New MOAs in prostate cancer treatment - what’s next? - ecancer ecancer.org/en/video/12402… MQ University Clinical Trials Unit

Clinical case submissions are now open for the Yin & Yang Lung Cancer Masterclass! July 11-12, 2025 in Milan, Italy <40? Oncologist, surgeon, or rad onc? Submit by June 15! Submit a case on one of the topics: 1️⃣ Multimodal Rx (resectable/LA NSCLC) 2️⃣ Adjuvant EGFR/ALK+ NSCLC 3️⃣

Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study ascopubs.org/doi/10.1200/JC… This phase I trial of pasritamig, a novel bispecific T-cell–engaging antibody targeting KLK2 in

Thankful 🙏🏻 to the Polish Young Oncologist 🤩 forum Pawel Sobczuk Michal Wilk Young SIOG for their invitation to raise awarness on clinical trials in 👴🏼👵🏼. Great discussions and interactions with Young oncologists and great panels Teresa Amaral, MD, PhD Marco Donia